Focus: Orchestra BioMed is a newly founded (2024) medical device company focused on cardiovascular interventions, based in New Hope, PA. The company is pre-commercial with a nascent pipeline and minimal public operational footprint.
Profile data last refreshed 4m ago · AI intelligence enriched 1mo ago
Hot — 43 jobs added in 30d
Net +39 (43 new, 4 removed). Aggressive expansion phase.
Orchestra BioMed presents a high-risk, early-stage opportunity suitable only for founders/early employees with appetite for pre-revenue biotech uncertainty and cardiovascular device expertise.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Orchestra BioMed
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Orchestra BioMed's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo